Skip to content

Nuo Therapeutics, Inc.: 10-Q filed 2015-08-13

What Nuo Therapeutics, Inc. reported in its quarterly report filed 2015-08-13 (fiscal Q2 2015): 42 published measures, 120 facts as tagged in accession 0001144204-15-049126.

This filing

Form
10-Q (quarterly report)
Filed
2015-08-13
Fiscal period
fiscal Q2 2015
Accession
0001144204-15-049126 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Nuo Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-3046,466,803USD
At 2014-12-3156,224,605USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-06-3026,739,773USD
At 2014-12-3140,257,053USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-3019,227,030USD
At 2014-12-3115,467,552USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-306,885,534USD
At 2014-12-3115,946,425USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-870,238USD91
2015-01-01 to 2015-06-303,236,763USD181
2014-04-01 to 2014-06-30-11,320,638USD91
2014-01-01 to 2014-06-30-16,953,551USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-06-30165,817USD181
2014-01-01 to 2014-06-3076,213USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-04-01 to 2015-06-302,895,231USD91
2015-01-01 to 2015-06-307,732,358USD181
2014-04-01 to 2014-06-302,326,104USD91
2014-01-01 to 2014-06-304,172,033USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-106,875,085USD
At 2014-12-31-110,111,848USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2015-04-01 to 2015-06-30125,951,100shares91
2015-01-01 to 2015-06-30125,951,100shares181
2014-04-01 to 2014-06-30121,638,826shares91
2014-01-01 to 2014-06-30116,459,607shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2015-04-01 to 2015-06-30125,951,100shares91
2015-01-01 to 2015-06-30125,951,100shares181
2014-04-01 to 2014-06-30121,638,826shares91
2014-01-01 to 2014-06-30116,459,607shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-0.01USD/shares91
2015-01-01 to 2015-06-300.01USD/shares181
2014-04-01 to 2014-06-30-0.09USD/shares91
2014-01-01 to 2014-06-30-0.15USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-0.01USD/shares91
2015-01-01 to 2015-06-300.01USD/shares181
2014-04-01 to 2014-06-30-0.09USD/shares91
2014-01-01 to 2014-06-30-0.15USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2015-04-01 to 2015-06-304,896USD91
2015-01-01 to 2015-06-309,767USD181
2014-04-01 to 2014-06-304,645USD91
2014-01-01 to 2014-06-309,290USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-30874,050USD
At 2014-12-31925,171USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-04-01 to 2015-06-30188,323USD91
2015-01-01 to 2015-06-30522,715USD181
2014-04-01 to 2014-06-30370,589USD91
2014-01-01 to 2014-06-30548,589USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-4,437,017USD91
2015-01-01 to 2015-06-30-7,807,786USD181
2014-04-01 to 2014-06-30-9,822,490USD91
2014-01-01 to 2014-06-30-14,472,650USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-3012,825,538USD
At 2014-12-3121,876,140USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-307,861,323USD
At 2014-12-318,498,337USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-06-301,738,135USD
At 2014-12-311,877,736USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2015-06-301,128,517USD
At 2014-12-311,128,517USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-04-01 to 2015-06-304,950,451USD91
2015-01-01 to 2015-06-3010,333,010USD181
2014-04-01 to 2014-06-3010,251,101USD91
2014-01-01 to 2014-06-3015,294,125USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-06-30717,087USD
At 2014-12-31556,620USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2015-04-01 to 2015-06-30513,434USD91
2015-01-01 to 2015-06-302,525,224USD181
2014-04-01 to 2014-06-30428,611USD91
2014-01-01 to 2014-06-30821,475USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2015-04-01 to 2015-06-302,381,797USD91
2015-01-01 to 2015-06-305,207,134USD181
2014-04-01 to 2014-06-301,897,493USD91
2014-01-01 to 2014-06-303,350,558USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-04-01 to 2015-06-30597,844USD91
2015-01-01 to 2015-06-301,332,334USD181
2014-04-01 to 2014-06-301,313,488USD91
2014-01-01 to 2014-06-302,747,087USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-30125,680,100shares
At 2014-12-31125,680,100shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-06-30125,696,688USD
At 2014-12-31125,173,973USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2015-06-3028,593,582USD
At 2014-12-3128,747,770USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-06-303,045,116USD
At 2014-12-313,547,007USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-06-30497,260USD
At 2014-12-31546,867USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-06-305,720,811USD
At 2014-12-316,218,224USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-06-301,903,420USD
At 2014-12-312,338,990USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-865,342USD91
2015-01-01 to 2015-06-303,246,530USD181
2014-04-01 to 2014-06-30-11,315,993USD91
2014-01-01 to 2014-06-30-16,944,261USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-870,238USD91
2015-01-01 to 2015-06-301,835,612USD181
2014-04-01 to 2014-06-30-11,320,638USD91
2014-01-01 to 2014-06-30-16,953,551USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-302,569,475USD91
2015-01-01 to 2015-06-305,395,447USD181
2014-04-01 to 2014-06-303,054,387USD91
2014-01-01 to 2014-06-305,186,123USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2015-01-01 to 2015-06-30345,722USD181
2014-01-01 to 2014-06-30438,570USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2015-04-01 to 2015-06-301,163USD91
2015-01-01 to 2015-06-30-15,116USD181
2014-04-01 to 2014-06-30-1,239USD91
2014-01-01 to 2014-06-30-1,239USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-04-01 to 2015-06-303,571,675USD91
2015-01-01 to 2015-06-3011,054,316USD181
2014-04-01 to 2014-06-30-1,493,503USD91
2014-01-01 to 2014-06-30-2,471,611USD181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2015-01-01 to 2015-06-309,767USD181
2014-01-01 to 2014-06-309,290USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2015-01-01 to 2015-06-300USD181
2014-01-01 to 2014-06-303,666,260USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30173,707USD181
2014-01-01 to 2014-06-30-519,878USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-139,601USD181
2014-01-01 to 2014-06-30808,025USD181

Inspect the source

Entity
Nuo Therapeutics, Inc. / CIK 0001091596
Captured
2026-09-20T05:21:57.848Z
SEC response SHA-256
f9d1094a0912aec87dd50c0e6f3c9b7f90d3de5f7435cbf00ae5d71aa22d4723

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001091596.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))